Bendectin and Birth Defects : : The Challenges of Mass Toxic Substances Litigation / / Michael D. Green.
Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabi...
Saved in:
Superior document: | Title is part of eBook package: De Gruyter University of Pennsylvania Press Package Archive 1898-1999 |
---|---|
VerfasserIn: | |
Place / Publishing House: | Philadelphia : : University of Pennsylvania Press, , [2016] ©1996 |
Year of Publication: | 2016 |
Language: | English |
Online Access: | |
Physical Description: | 1 online resource (384 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
9781512816419 |
---|---|
ctrlnum |
(DE-B1597)469609 (OCoLC)952536854 |
collection |
bib_alma |
record_format |
marc |
spelling |
Green, Michael D., author. aut http://id.loc.gov/vocabulary/relators/aut Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation / Michael D. Green. Philadelphia : University of Pennsylvania Press, [2016] ©1996 1 online resource (384 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Frontmatter -- Contents -- Preface -- Acknowledgments -- Chapter 1. A Birth Defect Child Is Born -- Chapter 2. Locating Bendectin Within the Mass Toxic Landscape -- Chapter 3. The Science of Determining Toxic Causation -- Chapter 4. The Food and Drug Administration -- Chapter 5. The Wm. S. Merrell Company -- Chapter 6. A Mother's Quest -- Chapter 7. The Mekdeci Case -- Chapter 8. The Unraveling Of Mekdeci -- Chapter 9. The Proliferation of Bendectin Litigation -- Chapter 10. Litigating a Multidistrict Case -- Chapter 11. The Withdrawal of Bendectin -- Chapter 12. Forging a Mass Toxic Substances Trial -- Chapter 13. The Settlement and Unsettlement of MDL-486 -- Chapter 14. The MDL-486 Trial -- Chapter 15. Aggregative Procedure in Mass Toxic Substances Litigation -- Chapter 16. The Third Phase of Bendectin Litigation: Oxendine, Richardson, and the Individual Trials -- Chapter 17. The Legacy of Bendectin for Toxic Causation Law -- Chapter 18. The Lessons and Non-Lessons of Bendectin Litigation -- Selected Bibliography -- Index restricted access http://purl.org/coar/access_right/c_16ec online access with authorization star Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabilities would result in precedent-setting litigation. Before it was over, the Benedictin litigation would involve 2,000 claimants over a fifteen-year period. Michael D. Green offers a comprehensive overview of the Benedictin case and highlights many of the key issues in mass toxic substances litigation, comparing individual and collective forms of litigation, and illustrating the misunderstandings between scientists and lawyers about the role of science in providing evidence for the legal system. Issued also in print. Mode of access: Internet via World Wide Web. In English. Description based on online resource; title from PDF title page (publisher's Web site, viewed 30. Aug 2021) Bendectin (Trademark) Toxicology. Complex litigation United States. Products liability Drugs United States. Toxic torts United States. LAW / Malpractice. bisacsh Caregiving. Health. Human Rights. Law. Medicine. Title is part of eBook package: De Gruyter University of Pennsylvania Press Package Archive 1898-1999 9783110442526 print 9780812216455 https://doi.org/10.9783/9781512816419 https://www.degruyter.com/isbn/9781512816419 Cover https://www.degruyter.com/cover/covers/9781512816419.jpg |
language |
English |
format |
eBook |
author |
Green, Michael D., Green, Michael D., |
spellingShingle |
Green, Michael D., Green, Michael D., Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation / Frontmatter -- Contents -- Preface -- Acknowledgments -- Chapter 1. A Birth Defect Child Is Born -- Chapter 2. Locating Bendectin Within the Mass Toxic Landscape -- Chapter 3. The Science of Determining Toxic Causation -- Chapter 4. The Food and Drug Administration -- Chapter 5. The Wm. S. Merrell Company -- Chapter 6. A Mother's Quest -- Chapter 7. The Mekdeci Case -- Chapter 8. The Unraveling Of Mekdeci -- Chapter 9. The Proliferation of Bendectin Litigation -- Chapter 10. Litigating a Multidistrict Case -- Chapter 11. The Withdrawal of Bendectin -- Chapter 12. Forging a Mass Toxic Substances Trial -- Chapter 13. The Settlement and Unsettlement of MDL-486 -- Chapter 14. The MDL-486 Trial -- Chapter 15. Aggregative Procedure in Mass Toxic Substances Litigation -- Chapter 16. The Third Phase of Bendectin Litigation: Oxendine, Richardson, and the Individual Trials -- Chapter 17. The Legacy of Bendectin for Toxic Causation Law -- Chapter 18. The Lessons and Non-Lessons of Bendectin Litigation -- Selected Bibliography -- Index |
author_facet |
Green, Michael D., Green, Michael D., |
author_variant |
m d g md mdg m d g md mdg |
author_role |
VerfasserIn VerfasserIn |
author_sort |
Green, Michael D., |
title |
Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation / |
title_sub |
The Challenges of Mass Toxic Substances Litigation / |
title_full |
Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation / Michael D. Green. |
title_fullStr |
Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation / Michael D. Green. |
title_full_unstemmed |
Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation / Michael D. Green. |
title_auth |
Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation / |
title_alt |
Frontmatter -- Contents -- Preface -- Acknowledgments -- Chapter 1. A Birth Defect Child Is Born -- Chapter 2. Locating Bendectin Within the Mass Toxic Landscape -- Chapter 3. The Science of Determining Toxic Causation -- Chapter 4. The Food and Drug Administration -- Chapter 5. The Wm. S. Merrell Company -- Chapter 6. A Mother's Quest -- Chapter 7. The Mekdeci Case -- Chapter 8. The Unraveling Of Mekdeci -- Chapter 9. The Proliferation of Bendectin Litigation -- Chapter 10. Litigating a Multidistrict Case -- Chapter 11. The Withdrawal of Bendectin -- Chapter 12. Forging a Mass Toxic Substances Trial -- Chapter 13. The Settlement and Unsettlement of MDL-486 -- Chapter 14. The MDL-486 Trial -- Chapter 15. Aggregative Procedure in Mass Toxic Substances Litigation -- Chapter 16. The Third Phase of Bendectin Litigation: Oxendine, Richardson, and the Individual Trials -- Chapter 17. The Legacy of Bendectin for Toxic Causation Law -- Chapter 18. The Lessons and Non-Lessons of Bendectin Litigation -- Selected Bibliography -- Index |
title_new |
Bendectin and Birth Defects : |
title_sort |
bendectin and birth defects : the challenges of mass toxic substances litigation / |
publisher |
University of Pennsylvania Press, |
publishDate |
2016 |
physical |
1 online resource (384 p.) Issued also in print. |
contents |
Frontmatter -- Contents -- Preface -- Acknowledgments -- Chapter 1. A Birth Defect Child Is Born -- Chapter 2. Locating Bendectin Within the Mass Toxic Landscape -- Chapter 3. The Science of Determining Toxic Causation -- Chapter 4. The Food and Drug Administration -- Chapter 5. The Wm. S. Merrell Company -- Chapter 6. A Mother's Quest -- Chapter 7. The Mekdeci Case -- Chapter 8. The Unraveling Of Mekdeci -- Chapter 9. The Proliferation of Bendectin Litigation -- Chapter 10. Litigating a Multidistrict Case -- Chapter 11. The Withdrawal of Bendectin -- Chapter 12. Forging a Mass Toxic Substances Trial -- Chapter 13. The Settlement and Unsettlement of MDL-486 -- Chapter 14. The MDL-486 Trial -- Chapter 15. Aggregative Procedure in Mass Toxic Substances Litigation -- Chapter 16. The Third Phase of Bendectin Litigation: Oxendine, Richardson, and the Individual Trials -- Chapter 17. The Legacy of Bendectin for Toxic Causation Law -- Chapter 18. The Lessons and Non-Lessons of Bendectin Litigation -- Selected Bibliography -- Index |
isbn |
9781512816419 9783110442526 9780812216455 |
callnumber-first |
K - Law |
callnumber-subject |
KF - United States |
callnumber-label |
KF1297 |
callnumber-sort |
KF 41297 D7 G74 41996EB |
geographic_facet |
United States. |
url |
https://doi.org/10.9783/9781512816419 https://www.degruyter.com/isbn/9781512816419 https://www.degruyter.com/cover/covers/9781512816419.jpg |
illustrated |
Not Illustrated |
dewey-hundreds |
300 - Social sciences |
dewey-tens |
340 - Law |
dewey-ones |
346 - Private law 347 - Civil procedure & courts |
dewey-full |
346.7303/8 347.30638 |
dewey-sort |
3346.7303 18 |
dewey-raw |
346.7303/8 347.30638 |
dewey-search |
346.7303/8 347.30638 |
doi_str_mv |
10.9783/9781512816419 |
oclc_num |
952536854 |
work_keys_str_mv |
AT greenmichaeld bendectinandbirthdefectsthechallengesofmasstoxicsubstanceslitigation |
status_str |
n |
ids_txt_mv |
(DE-B1597)469609 (OCoLC)952536854 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Title is part of eBook package: De Gruyter University of Pennsylvania Press Package Archive 1898-1999 |
is_hierarchy_title |
Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation / |
container_title |
Title is part of eBook package: De Gruyter University of Pennsylvania Press Package Archive 1898-1999 |
_version_ |
1770177152827785216 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04735nam a22008295i 4500</leader><controlfield tag="001">9781512816419</controlfield><controlfield tag="003">DE-B1597</controlfield><controlfield tag="005">20210830012106.0</controlfield><controlfield tag="006">m|||||o||d||||||||</controlfield><controlfield tag="007">cr || ||||||||</controlfield><controlfield tag="008">210830t20161996pau fo d z eng d</controlfield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">(OCoLC)1013941474</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781512816419</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.9783/9781512816419</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-B1597)469609</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)952536854</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-B1597</subfield><subfield code="b">eng</subfield><subfield code="c">DE-B1597</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">pau</subfield><subfield code="c">US-PA</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">KF1297.D7</subfield><subfield code="b">G74 1996eb</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">LAW095000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">346.7303/8</subfield><subfield code="a">347.30638</subfield><subfield code="2">20</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Green, Michael D., </subfield><subfield code="e">author.</subfield><subfield code="4">aut</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bendectin and Birth Defects :</subfield><subfield code="b">The Challenges of Mass Toxic Substances Litigation /</subfield><subfield code="c">Michael D. Green.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia : </subfield><subfield code="b">University of Pennsylvania Press, </subfield><subfield code="c">[2016]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (384 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="b">PDF</subfield><subfield code="2">rda</subfield></datafield><datafield tag="505" ind1="0" ind2="0"><subfield code="t">Frontmatter -- </subfield><subfield code="t">Contents -- </subfield><subfield code="t">Preface -- </subfield><subfield code="t">Acknowledgments -- </subfield><subfield code="t">Chapter 1. A Birth Defect Child Is Born -- </subfield><subfield code="t">Chapter 2. Locating Bendectin Within the Mass Toxic Landscape -- </subfield><subfield code="t">Chapter 3. The Science of Determining Toxic Causation -- </subfield><subfield code="t">Chapter 4. The Food and Drug Administration -- </subfield><subfield code="t">Chapter 5. The Wm. S. Merrell Company -- </subfield><subfield code="t">Chapter 6. A Mother's Quest -- </subfield><subfield code="t">Chapter 7. The Mekdeci Case -- </subfield><subfield code="t">Chapter 8. The Unraveling Of Mekdeci -- </subfield><subfield code="t">Chapter 9. The Proliferation of Bendectin Litigation -- </subfield><subfield code="t">Chapter 10. Litigating a Multidistrict Case -- </subfield><subfield code="t">Chapter 11. The Withdrawal of Bendectin -- </subfield><subfield code="t">Chapter 12. Forging a Mass Toxic Substances Trial -- </subfield><subfield code="t">Chapter 13. The Settlement and Unsettlement of MDL-486 -- </subfield><subfield code="t">Chapter 14. The MDL-486 Trial -- </subfield><subfield code="t">Chapter 15. Aggregative Procedure in Mass Toxic Substances Litigation -- </subfield><subfield code="t">Chapter 16. The Third Phase of Bendectin Litigation: Oxendine, Richardson, and the Individual Trials -- </subfield><subfield code="t">Chapter 17. The Legacy of Bendectin for Toxic Causation Law -- </subfield><subfield code="t">Chapter 18. The Lessons and Non-Lessons of Bendectin Litigation -- </subfield><subfield code="t">Selected Bibliography -- </subfield><subfield code="t">Index</subfield></datafield><datafield tag="506" ind1="0" ind2=" "><subfield code="a">restricted access</subfield><subfield code="u">http://purl.org/coar/access_right/c_16ec</subfield><subfield code="f">online access with authorization</subfield><subfield code="2">star</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabilities would result in precedent-setting litigation. Before it was over, the Benedictin litigation would involve 2,000 claimants over a fifteen-year period. Michael D. Green offers a comprehensive overview of the Benedictin case and highlights many of the key issues in mass toxic substances litigation, comparing individual and collective forms of litigation, and illustrating the misunderstandings between scientists and lawyers about the role of science in providing evidence for the legal system.</subfield></datafield><datafield tag="530" ind1=" " ind2=" "><subfield code="a">Issued also in print.</subfield></datafield><datafield tag="538" ind1=" " ind2=" "><subfield code="a">Mode of access: Internet via World Wide Web.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">In English.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (publisher's Web site, viewed 30. Aug 2021)</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Bendectin (Trademark)</subfield><subfield code="x">Toxicology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Complex litigation</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Products liability</subfield><subfield code="x">Drugs</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Toxic torts</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LAW / Malpractice.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Caregiving.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Health.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Human Rights.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Law.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medicine.</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Title is part of eBook package:</subfield><subfield code="d">De Gruyter</subfield><subfield code="t">University of Pennsylvania Press Package Archive 1898-1999</subfield><subfield code="z">9783110442526</subfield></datafield><datafield tag="776" ind1="0" ind2=" "><subfield code="c">print</subfield><subfield code="z">9780812216455</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.9783/9781512816419</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.degruyter.com/isbn/9781512816419</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="3">Cover</subfield><subfield code="u">https://www.degruyter.com/cover/covers/9781512816419.jpg</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">978-3-11-044252-6 University of Pennsylvania Press Package Archive 1898-1999</subfield><subfield code="c">1898</subfield><subfield code="d">1999</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_BACKALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_CL_LAEC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_EBACKALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_EBKALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_ECL_LAEC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_EEBKALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_ESSHALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_ESTMALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_PPALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_SSHALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_STMALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV-deGruyter-alles</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA11SSHE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA12STME</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA13ENGE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA17SSHEE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA18STMEE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA5EBK</subfield></datafield></record></collection> |